These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30704101)

  • 21. Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.
    Shao L; Hewitt MC; Wang F; Malcolm SC; Ma J; Campbell JE; Campbell UC; Engel SR; Spicer NA; Hardy LW; Schreiber R; Spear KL; Varney MA
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1438-41. PubMed ID: 21310609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
    Hatzenbuhler NT; Evrard DA; Harrison BL; Huryn D; Inghrim J; Kraml C; Mattes JF; Mewshaw RE; Zhou D; Hornby G; Lin Q; Smith DL; Sullivan KM; Schechter LE; Beyer CE; Andree TH
    J Med Chem; 2006 Jul; 49(15):4785-9. PubMed ID: 16854086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and systematic evaluation of 4-arylpiperazine- and 4-benzylpiperidine napthyl ethers as inhibitors of monoamine neurotransmitters reuptake.
    Paudel S; Min X; Acharya S; Khadka DB; Yoon G; Kim KM; Cheon SH
    Bioorg Med Chem; 2018 Nov; 26(20):5538-5546. PubMed ID: 30293797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arylpiperazine-containing pyrrole 3-carboxamide derivatives targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant.
    Kang SY; Park EJ; Park WK; Kim HJ; Jeong D; Jung ME; Song KS; Lee SH; Seo HJ; Kim MJ; Lee M; Han HK; Son EJ; Pae AN; Kim J; Lee J
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1705-11. PubMed ID: 20149649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.
    Bymaster FP; Beedle EE; Findlay J; Gallagher PT; Krushinski JH; Mitchell S; Robertson DW; Thompson DC; Wallace L; Wong DT
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4477-80. PubMed ID: 14643350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.
    Paudel S; Cao Y; Guo S; An B; Kim KM; Cheon SH
    Bioorg Med Chem; 2015 Oct; 23(19):6418-26. PubMed ID: 26337019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.
    Voelker T; Xia H; Fandrick K; Johnson R; Janowsky A; Cashman JR
    Bioorg Med Chem; 2009 Mar; 17(5):2047-68. PubMed ID: 19201198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.
    Carlier PR; Lo MM; Lo PC; Richelson E; Tatsumi M; Reynolds IJ; Sharma TA
    Bioorg Med Chem Lett; 1998 Mar; 8(5):487-92. PubMed ID: 9871604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of LPM570065, a novel triple reuptake inhibitor, on extracellular serotonin, dopamine and norepinephrine levels in rats.
    Zhang R; Li X; Shi Y; Shao Y; Sun K; Wang A; Sun F; Liu W; Wang D; Jin J; Li Y
    PLoS One; 2014; 9(3):e91775. PubMed ID: 24614602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties.
    Artaiz I; Zazpe A; Innerárity A; Del Olmo E; Díaz A; Ruiz-Ortega JA; Castro E; Pena R; Labeaga L; Pazos A; Orjales A
    Psychopharmacology (Berl); 2005 Nov; 182(3):400-13. PubMed ID: 16032410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter.
    Seo HJ; Park EJ; Kim MJ; Kang SY; Lee SH; Kim HJ; Lee KN; Jung ME; Lee M; Kim MS; Son EJ; Park WK; Kim J; Lee J
    J Med Chem; 2011 Sep; 54(18):6305-18. PubMed ID: 21823597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and antidepressant effect of novel aralkyl piperazine and piperidine derivatives targeting SSRI/5-HT
    Gu ZS; Wang WT; Qian H; Zhou AN; Sun HB; Zhang QW; Li JQ
    Bioorg Med Chem Lett; 2019 Dec; 29(23):126703. PubMed ID: 31627993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Synthesis and antidepressant activities of aryl alkanol piperidine derivatives].
    Zheng YY; Gao K; Weng ZJ; Li JQ
    Yao Xue Xue Bao; 2010 Mar; 45(3):324-9. PubMed ID: 21351508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antidepressant activity of novel 1-(1-benzoylpiperidin-4-yl) methanamine derivatives selectively targeting SSRI/5-HT
    Yuan RX; Jiang KY; Wu JW; Zhang ZX; Li MS; Li JQ; Ni F
    Bioorg Med Chem Lett; 2022 Nov; 76():129006. PubMed ID: 36202190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and evaluation of novel 2,3-dihydrobenzo[b][1,4]dioxin- and indolealkylamine derivatives as potential antidepressants.
    Wang S; Chen Y; Liu X; Xu X; Liu X; Liu BF; Zhang G
    Arch Pharm (Weinheim); 2014 Jan; 347(1):32-41. PubMed ID: 24214603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further SAR studies of piperidine-based analogues of cocaine. 2. Potent dopamine and serotonin reuptake inhibitors.
    Tamiz AP; Zhang J; Flippen-Anderson JL; Zhang M; Johnson KM; Deschaux O; Tella S; Kozikowski AP
    J Med Chem; 2000 Mar; 43(6):1215-22. PubMed ID: 10737754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.
    Fish PV; Deur C; Gan X; Greene K; Hoople D; Mackenny M; Para KS; Reeves K; Ryckmans T; Stiff C; Stobie A; Wakenhut F; Whitlock GA
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2562-6. PubMed ID: 18387300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.
    Bang-Andersen B; Ruhland T; Jørgensen M; Smith G; Frederiksen K; Jensen KG; Zhong H; Nielsen SM; Hogg S; Mørk A; Stensbøl TB
    J Med Chem; 2011 May; 54(9):3206-21. PubMed ID: 21486038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
    Beyer CE; Boikess S; Luo B; Dawson LA
    J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.